Transcriptomic signatures as biomarkers for the progression of mild cognitive impairment
Objective Mild cognitive impairment (MCI) is acknowledged as an early and potentially modifiable stage of Alzheimer’s disease (AD). Despite this, there is a paucity of reliable molecular markers for predicting MCI progression. This study utilizes next-generation sequencing to elucidate alterations in RNA expression wit...